Vitae Pharmaceuticals
Fort Washington
About Vitae Pharmaceuticals
Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets with significant unmet medical needs, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $94.0M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2009)
- Ticker: nasdaq:VTAE
- Website: vitaepharma.com
- Phone: 2154612016
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/vitae-pharmaceuticals-816003 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.